Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Hair loss patients may have different polyamine levels in various scalp areas.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Laminin-511 may help promote hair growth, while laminin-332 does not affect hair loss.

Finasteride potentially treats hair loss by reducing DHT production.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Alginate spheres help maintain hair growth potential in human cells for hair loss treatment.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Better hair loss models needed for research.

Equisetum debile extracts may help with skin whitening, anti-wrinkle, and anti-hair loss treatments.

Stem cell treatments show promise for hair loss but need more research.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.

Ostrich antibodies can help restore hair growth in people with a specific type of hair loss, increasing hair count by 71% on average.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.